A health worker administers a COVID-19 vaccine shot to a resident in Los Angeles, the United States, on Dec. 17, 2022. (Xinhua)
Nearly 90,000 adults and children are participating in RECOVER observational studies through more than 300 clinical research sites across the country.
LOS ANGELES, Feb. 13 (Xinhua) -- About one in nine adults in the United States who have ever had COVID-19 continue to experience Long COVID with a wide range of symptoms, according to new data of the U.S. Centers for Disease Control and Prevention (CDC).
To bolster Long COVID research efforts, the U.S. National Institutes of Health (NIH) announced on Tuesday it is investing an additional 515 million U.S. dollars over the next four years into the Researching COVID to Enhance Recovery (RECOVER) Initiative, a nationwide research program to fully understand, diagnose and treat Long COVID.
Nearly 90,000 adults and children are participating in RECOVER observational studies through more than 300 clinical research sites across the country, according to NIH.
RECOVER findings, including the identification of major symptom clusters, are helping clinical researchers broaden the identification of Long COVID in their patients and ultimately helping to inform diagnosis, treatment and care for all those suffering from Long COVID, said NIH. ■